# Eaton Vance Enhanced Equity Income Fund II: filings

EOS · NYSE · CIK 1308335 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eos.md) · [Financials](/companies/eos/financials.md) · [Filings](/companies/eos/filings.md) · [Insiders](/companies/eos/insiders.md)

## Reports and events: 23 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (NPORT-P 28, 3 27, 4 24, 424B3 20, N-Q 20, DEF 14A 18, N-CSR 18, N-CSRS 18, N-PX 18, 497 16, NSAR-B 10, NSAR-A 9, N-CEN 8, 5 6, 8-K 5, DEFA14A 4, CORRESP 3, POS EX 3, SC 13G/A 3, 40-17GCS 2, 424B5 2, 486BPOS 2, N-2ASR 2, SC 13G 2, DEFR14A 1, EFFECT 1, N-2 1, N-2/A 1, N-CSRS/A 1, NPORT-EX 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-02-25 | 09:52 ET | [DEF 14A](/filings/0001133228-26-002051.md) | Proxy statement, period 2026-04-08 | 0001133228-26-002051 |
| 2025-08-28 | 13:52 ET | [8-K](/filings/0001076598-25-000384.md) | 8.01 Other events | 0001076598-25-000384 |
| 2025-08-14 | 14:12 ET | [8-K](/filings/0001076598-25-000326.md) | 8.01 Other events | 0001076598-25-000326 |
| 2025-02-27 | 10:24 ET | [DEF 14A](/filings/0000940394-25-000250.md) | Proxy statement, period 2025-04-09 | 0000940394-25-000250 |
| 2024-10-10 | 16:08 ET | [8-K](/filings/0000940394-24-000991.md) | 5.03 Amendment to articles or bylaws | 0000940394-24-000991 |
| 2024-02-23 | 07:56 ET | [DEF 14A](/filings/0000940394-24-000192.md) | Proxy statement, period 2024-04-10 | 0000940394-24-000192 |
| 2023-02-24 | 08:51 ET | [DEF 14A](/filings/0000940394-23-000309.md) | Proxy statement, period 2023-04-12 | 0000940394-23-000309 |
| 2023-02-01 | 16:13 ET | [8-K](/filings/0000940394-23-000228.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000940394-23-000228 |
| 2022-02-24 | 08:24 ET | [DEF 14A](/filings/0000940394-22-000238.md) | Proxy statement, period 2022-04-14 | 0000940394-22-000238 |
| 2021-02-23 | 08:04 ET | [DEF 14A](/filings/0000940394-21-000444.md) | Proxy statement, period 2021-04-15 | 0000940394-21-000444 |
| 2020-08-13 | 16:06 ET | [8-K](/filings/0000940394-20-001209.md) | 5.03 Amendment to articles or bylaws | 0000940394-20-001209 |
| 2020-02-24 | 07:47 ET | [DEF 14A](/filings/0000940394-20-000284.md) | Proxy statement, period 2020-04-16 | 0000940394-20-000284 |
| 2019-02-22 | 08:36 ET | [DEF 14A](/filings/0000940394-19-000363.md) | Proxy statement, period 2019-04-18 | 0000940394-19-000363 |
| 2018-02-27 | 07:47 ET | [DEF 14A](/filings/0000940394-18-000344.md) | Proxy statement, period 2018-04-19 | 0000940394-18-000344 |
| 2017-02-27 | 08:37 ET | [DEF 14A](/filings/0000940394-17-000324.md) | Proxy statement, period 2017-04-20 | 0000940394-17-000324 |
| 2016-02-26 | 08:37 ET | [DEF 14A](/filings/0000940394-16-002009.md) | Proxy statement, period 2016-04-21 | 0000940394-16-002009 |
| 2015-02-27 | 09:05 ET | [DEF 14A](/filings/0000940394-15-000302.md) | Proxy statement, period 2015-04-23 | 0000940394-15-000302 |
| 2014-02-27 | 08:38 ET | [DEF 14A](/filings/0000940394-14-000275.md) | Proxy statement, period 2014-04-24 | 0000940394-14-000275 |
| 2013-02-26 | 09:09 ET | [DEF 14A](/filings/0000940394-13-000292.md) | Proxy statement, period 2013-04-19 | 0000940394-13-000292 |
| 2012-02-22 | 13:02 ET | [DEF 14A](/filings/0000940394-12-000154.md) | Proxy statement, period 2012-04-20 | 0000940394-12-000154 |
| 2011-02-22 | 10:11 ET | [DEF 14A](/filings/0000940394-11-000166.md) | Proxy statement, period 2011-04-22 | 0000940394-11-000166 |
| 2010-02-22 | 14:59 ET | [DEF 14A](/filings/0000940394-10-000137.md) | Proxy statement, period 2010-04-23 | 0000940394-10-000137 |
| 2009-02-23 | 17:04 ET | [DEF 14A](/filings/0000940394-09-000100.md) | Proxy statement, period 2009-04-24 | 0000940394-09-000100 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 14:20 ET. No prices; not investment advice.